EGFR and neoplasm: As schematically depicted in Fig. 7, LRP-1 receptor maintains stability of tyrosine-phosphorylated EGFR signalling at one hand and mediates the tumour cell-secreted eHsp90α autocrine signalling on the other hand, to achieve a full self-supported motility that reaches about 60% of the full cell motility under physiological conditions.